Target intelligence / Profile preview

Splicing factor ESS-2 homolog (ESS2)

Target
ESS2
Molecular classification
Spliceosome-associated protein, Splicing factor, Transcriptional coregulator, Other
01

Overview

Splicing factor ESS-2 homolog (ESS2) is a peripheral component of the spliceosome found in humans and other eukaryotes, encoded by a gene in the DiGeorge syndrome 22q11.2 deletion region. ESS2 is critical for the regulation of pre-mRNA splicing with specific roles in the transition and assembly of C and C* spliceosome complexes. In addition to its splicing function, ESS2 acts as a transcriptional coregulator, influencing the expression of genes involved in cell differentiation, proliferation, neuronal development, and immune responses. ESS2 has direct interactions with key splicing and transcriptional regulatory proteins, including nuclear hormone receptors. Loss of ESS2 function leads to early embryonic lethality in mice, and dysregulation is implicated in cancer, neurodevelopmental, and autoimmune disorders. The molecular details of ESS2's dual roles in splicing and transcriptional regulation are still under investigation. No drugs are currently known to directly target ESS2, but its central regulatory role makes it a candidate biomarker and a potential future therapeutic target in diseases involving disrupted splicing or transcription regulation[1][2][5].

Other names
ESS2DGCR13DGCR14DGSHDGSIES2DGS-HDGS-IEs2elbis1Splicing factor ESS-2 homologProtein ES2DiGeorge syndrome critical region 13DiGeorge syndrome critical region 14DiGeorge syndrome protein HDiGeorge syndrome gene HDiGeorge syndrome gene IProtein DGCR13Protein DGCR14ess-2 splicing factor homolog
02

Biological functions

Pre-mRNA splicingRegulation of mRNA splicing fidelityTranscriptional co-regulationCell differentiationCell proliferationNeuron developmentImmune cell (T cell) differentiationOther
03

Disease associations

Neurodevelopmental disorderAutoimmune diseaseCancerOther (potential biomarker in neural and immune diseases)
04

Biomarkers

Potential biomarker candidate in cancerPotential biomarker in neurodevelopmental disorderPotential biomarker in autoimmune disease

Beyond the preview

Go deeper on Splicing factor ESS-2 homolog (ESS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Splicing factor ESS-2 homolog (ESS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call